Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

Axovant is founded and financed by Roivant and its CEO Vivek Ramaswamy, whose central strategy is to buy drugs that have been abandoned or shelved by big pharma and successfully bring them to market.

formerly known as Axovant and one of the 'vant' companies originally founded by entrepreneur Vivek Ramaswamy. Sio's board of directors has decided it is time to call it quits and abandon the ...

Industries showering Trump with cash included Big Oil, Big Tech, Big Pharma, Big Tobacco, Wall Street, crypto and private prison interests, and more. Many of the corporate donors are poised to win ...

The biotech entrepreneur hopes for support from both President Trump and Elon Musk as he maps out his planned bid for Ohio ...

When Vivek Ramaswamy formally launches his expected bid to succeed Ohio Gov. Mike DeWine (R), the biotech entrepreneur and ...

Goldman Sachs analyst warns 340B reforms could shift profits to biopharma, benefiting companies like Merck and Gilead. Proposed Medicaid cuts may create risks for biopharma, impacting drugs like ...

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order ...

Former presidential candidate Vivek Ramaswamy is calling out the national security risk of having a generation dependent on China as U.S. students fall behind in the classroom. "75% of eighth ...

Former presidential candidate Vivek Ramaswamy is calling out the national security risk of having a generation dependent on China as U.S. students fall behind in the classroom. "75% of eighth graders ...

CLEVELAND, OH — Vivek Ramaswamy, once a key figure in the Trump circles and slated to head the Department of Government Efficiency (DOGE), has recently found himself out of the headlines.